Arysta LifeScience restructures Latin American business

Arysta LifeScience Corporation has announced that it is restructuring its Latin American business unit to include Mexico and Central America in order to better leverage the strong cultural and strategic alignment among those markets. Until now, the company’s operations in Mexico and Central America had functioned as part of its North American business unit.

"When we acquired the Grupo Bioquímico Mexicano (GBM) business several years ago, one of the key benefits was the strength it brought to our overall presence in the high-value fruit and vegetable crop market in South America,” said Flavio Prezzi, Business Unit Head for Latin America. “The GBM portfolio of plant nutrients and growth stimulants is a natural fit with the needs of growers throughout Latin America. Now we have the opportunity to leverage the combined GBM and Arysta LifeScience portfolios across a broad region of growers who want both plant nutrients and proprietary crop protection products.”

Prezzi has extensive experience in Mexico and Central America, having served as president and CEO for Syngenta in Mexico, as well as general manager for Syngenta in the Central America region, prior to joining Arysta LifeScience. Luis Villa, who played a critical role in the 2007 acquisition of GBM, will remain the Manager for Arysta LifeScience Mexico and Central America, reporting to Prezzi.

"This restructuring will integrate our efforts throughout the region, create synergy, and promote the sharing of knowledge, which will benefit all of the growers we serve,” added Villa.

When the restructuring is completed by the end of the year, the new Latin American business unit will be the largest of the six Arysta LifeScience business units worldwide (Latin America, North America, Europe, Africa Middle East, North Asia and South Asia).